Strategic use of conformational bias and structure based design to identify potent JAK3 inhibitors with improved selectivity against the JAK family and the kinome

被引：35

作者：

Lynch, Stephen M. ^{[1
]}

DeVicente, Javier ^{[1
]}

Hermann, Johannes C. ^{[1
]}

Jaime-Figueroa, Saul ^{[1
]}

Jin, Sue ^{[2
]}

Kuglstatter, Andreas ^{[3
]}

Li, Hongju ^{[1
]}

Lovey, Allen ^{[1
]}

Menke, John ^{[2
]}

Niu, Linghao ^{[2
]}

Patel, Vaishali ^{[2
]}

Roy, Douglas ^{[1
]}

Soth, Michael ^{[1
]}

Steiner, Sandra ^{[1
]}

Tivitmahaisoon, Parcharee ^{[1
]}

Minh Diem Vu ^{[2
]}

Yee, Calvin ^{[1
]}

机构：

[1] Hoffmann La Roche Inc, Discovery Chem, pRED, Nutley, NJ 07110 USA

[2] Hoffmann La Roche Inc, Inflammat Biol, pRED, Nutley, NJ 07110 USA

[3] Hoffmann La Roche Inc, Discovery Technol, pRED, Nutley, NJ 07110 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2013年 / 23卷 / 09期

关键词：

Kinase inhibitors; Janus kinase; JAK; Structure based design; Kinase selectivity; Conformational bias; RHEUMATOID-ARTHRITIS; JANUS KINASES; TRANSPLANT REJECTION; DISCOVERY; CP-690,550; PSORIASIS; EFFICACY;

D O I：

10.1016/j.bmcl.2013.02.012

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Using a structure based design approach we have identified a series of indazole substituted pyrrolopyrazines, which are potent inhibitors of JAK3. Intramolecular electronic repulsion was used as a strategy to induce a strong conformational bias within the ligand. Compounds bearing this conformation participated in a favorable hydrophobic interaction with a cysteine residue in the JAK3 binding pocket, which imparted high selectivity versus the kinome and improved selectivity within the JAK family. (C) 2013 Published by Elsevier Ltd.

引用

页码：2793 / 2800

页数：8

共 38 条

[21] JAK3 inhibitors based on thieno[3,2-d]pyrimidine scaffold: design, synthesis and bioactivity evaluation for the treatment of B-cell lymphoma
Chi, Fuyun
Chen, Lixue
Wang, Changyuan
Li, Lei
Sun, Xiuli
Xu, Youjun
Ma, Tengyue
Liu, Kexin
Ma, Xiaodong
Shu, Xiaohong
BIOORGANIC CHEMISTRY, 2020, 95
[22] Ligand-based and e-pharmacophore modeling, 3D-QSAR and hierarchical virtual screening to identify dual inhibitors of spleen tyrosine kinase (Syk) and janus kinase 3 (JAK3)
Kaur, Maninder
Silakari, Om
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2017, 35 (14): : 3043 - 3060
[23] Computer-Aided Drug Design of Novel Derivatives of 2-Amino-7,9-dihydro-8H-purin-8-one as Potent Pan-Janus JAK3 Inhibitors
Faris, Abdelmoujoud
Ibrahim, Ibrahim M. M.
Al Kamaly, Omkulthom
Saleh, Asmaa
Elhallaoui, Menana
MOLECULES, 2023, 28 (15):
[24] Novel 1H-pyrazolo[3,4-d]pyrimidin-6-amino derivatives as potent selective Janus kinase 3 (JAK3) inhibitors. Evaluation of their improved effect for the treatment of rheumatoid arthritis
Yin, Yuan
Chen, Cheng-Juan
Yu, Ru-Nan
Shu, Lei
Wang, Zhi-Jian
Zhang, Tian-Tai
Zhang, Da-Yong
BIOORGANIC CHEMISTRY, 2020, 98
[25] Use of structure based design to increase selectivity of pyridyl-cinnoline phosphodiesterase 10A (PDE10A) inhibitors against phosphodiesterase 3 (PDE3)
Hu, Essa
Kunz, Roxanne K.
Rumfelt, Shannon
Andrews, Kristin L.
Li, Chun
Hitchcock, Stephen A.
Lindstrom, Michelle
Treanor, James
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (22) : 6938 - 6942
[26] Development, Optimization, and Structure-Activity Relationships of Covalent-Reversible JAK3 Inhibitors Based on a Tricyclic Imidazo[5,4-d]pyrrolo[2,3-b]pyridine Scaffold
Forster, Michael
Chaikuad, Apirat
Dimitrov, Teodor
Doering, Eva
Holstein, Julia
Berger, Benedict-Tilman
Gehringer, Matthias
Ghoreschi, Kamran
Mueller, Susanne
Knapp, Stefan
Laufer, Stefan A.
JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (12) : 5350 - 5366
[27] Structure-based design of oxygen-linked macrocyclic kinase inhibitors: discovery of SB1518 and SB1578, potent inhibitors of Janus kinase 2 (JAK2) and Fms-like tyrosine kinase-3 (FLT3)
Anders Poulsen
Anthony William
Stéphanie Blanchard
Angeline Lee
Harish Nagaraj
Haishan Wang
Eeling Teo
Evelyn Tan
Kee Chuan Goh
Brian Dymock
Journal of Computer-Aided Molecular Design, 2012, 26 : 437 - 450
[28] Structure-based design of oxygen-linked macrocyclic kinase inhibitors: discovery of SB1518 and SB1578, potent inhibitors of Janus kinase 2 (JAK2) and Fms-like tyrosine kinase-3 (FLT3)
Poulsen, Anders
William, Anthony
Blanchard, Stephanie
Lee, Angeline
Nagaraj, Harish
Wang, Haishan
Teo, Eeling
Tan, Evelyn
Goh, Kee Chuan
Dymock, Brian
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2012, 26 (04) : 437 - 450
[29] Structure-guided design of potent JAK1-selective inhibitors based on 4-amino-7H-pyrrolo[2,3-d]pyrimidine with anti-inflammatory efficacy
Zhang, Jiahao
Xing, Shuming
Cui, Jianming
Wei, Xiujian
Cao, Zhi
Shao, Bin
Jiang, Nan
Zhai, Xin
ARCHIV DER PHARMAZIE, 2024, 357 (04)
[30] Identification of potent and selective small-molecule inhibitors of caspase-3 through the use of extended tethering and structure-based drug design
Choong, IC
Lew, W
Lee, D
Pham, P
Burdett, MT
Lam, JW
Wiesmann, C
Luong, TN
Fahr, B
DeLano, WL
McDowell, RS
Allen, DA
Erlanson, DA
Gordon, EM
O'Brien, T
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (23) : 5005 - 5022

← 1 2 3 4 →